Table 3 Cox uni-and multivariable analysis of relative risk of death from colorectal cancer, rectal cancer, and left hemicolon cancer within 5 years by HES9 expression
From: Podocalyxin is a marker of poor prognosis in colorectal cancer
Colorectal cancer-specific survival | Left hemicolon cancer-specific survival | Rectal cancer-specific survival | |||||||
|---|---|---|---|---|---|---|---|---|---|
HR (95% CI) | p-value | n (events) | HR (95% CI) | p-value | n (events) | HR (95% CI) | p-value | n (events) | |
Univariable | |||||||||
HES9 low | 1.00 | 723 (266) | 1.00 | 534 (194) | 1.00 | 351 (125) | |||
High | 2.00 (1.31–3.06) | 0.001 | 44 (23) | 2.60 (1.45–4.66) | 0.001 | 21 (12) | 3.03 (1.54–5.60) | 0.001 | 16 (9) |
Multivariable | |||||||||
HES9 low | 1.00 | 719 (266) | 1.00 | 532 (194) | 1.00 | 351 (125) | |||
High | 1.82 (1.15–2.86) | 0.01 | 44 (23) | 2.59 (1.41–4.88) | 0.002 | 21 (12) | 2.69 (1.30–5.54) | 0.007 | 16 (9) |